Qiuhua Deng

2.1k total citations · 1 hit paper
38 papers, 1.1k citations indexed

About

Qiuhua Deng is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Qiuhua Deng has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Qiuhua Deng's work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (13 papers) and Cancer Genomics and Diagnostics (12 papers). Qiuhua Deng is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (13 papers) and Cancer Genomics and Diagnostics (12 papers). Qiuhua Deng collaborates with scholars based in China, Denmark and United States. Qiuhua Deng's co-authors include Jianxing He, Wenlong Shao, Wenhua Liang, Xiaoshun Shi, Xinguo Xiong, Deruo Liu, Gening Jiang, Qun Wang, Zheng Wang and Lunxu Liu and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Qiuhua Deng

37 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non–Small-Cell Lung Cancer

2015 470 citations Wenhua Liang, Qiuhua Deng et al. profile →

Peers

Countries citing papers authored by Qiuhua Deng

Since Specialization

Citations

This map shows the geographic impact of Qiuhua Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuhua Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuhua Deng more than expected).

Fields of papers citing papers by Qiuhua Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiuhua Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuhua Deng. The network helps show where Qiuhua Deng may publish in the future.

Co-authorship network of co-authors of Qiuhua Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Qiuhua Deng. A scholar is included among the top collaborators of Qiuhua Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiuhua Deng. Qiuhua Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High-throughput virtual screening to identify potential small molecule inhibitors of the Zα domain of the adenosine deaminases acting on RNA 1(ADAR1) 2023 ·European Journal of Pharmaceutical Sciences ·(unknown), (unknown), Lulu He, (unknown), (unknown), (unknown), (unknown), Qiuhua Deng, (unknown), Yongmei Huang, Yu Cai, (unknown), Yu Lin	7
2	Comparative analysis of genomic profiles between tissue-based and plasma-based next-generation sequencing in patients with non-small cell lung cancer 2023 ·Lung Cancer ·(unknown), Yuqin Li, Shiqi Tang, Qiuhua Deng, Juhong Jiang, Chengzhi Zhou	12
3	Cell pellet from fixative medium of transbronchial lung biopsy sample improves lung cancer ancillary test 2022 ·Lung Cancer ·Juhong Jiang, Chunli Tang, Yuqin Li, (unknown), Zhi Li, Chengzhi Zhou, Yingying Gu, Ping He, Qing Tang, Yuxin Zhang, Qiuhua Deng, Yimin Ge, Wenhua Liang, Jianxing He	5
4	Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions 2022 ·Frontiers in Oncology ·Yuan Qiu, Liping Liu, (unknown), Hanzhang Chen, Qiuhua Deng, Dakai Xiao, (unknown), Changbin Zhu, Weiwei Li, Ди Шао, Wenxi Jiang, Kui Wu, Jianxing He	3
5	High Tumor Mutation Burden and DNA Repair Gene Mutations are Associated with Primary Resistance to Crizotinib in ALK-Rearranged Lung Cancer 2021 ·OncoTargets and Therapy ·Dakai Xiao, Qiuhua Deng, (unknown), Ying Huang, Wenchi Liang, (unknown), Haihong Yang	8
6	The characterization of lung microbiome in lung cancer patients with different clinicopathology. 2019 ·PubMed Central ·Danhui Huang, (unknown), Man Yuan, Shujia Zhang, Jing He, Qiuhua Deng, Wenjun Qiu, Hangming Dong, Shaoxi Cai	95
7	A Novel Next-Generation Sequencing Approach without Donor-Derived Material for Acute Rejection and Infection Monitoring in Solid Organ Transplantation 2018 ·Journal of Cancer Therapy ·Bing Wei, (unknown), Ди Шао, (unknown), Qing Yang, Jibin Zhang, Xiao Dong, Qiuhua Deng, (unknown), (unknown), Liping Liu, Xin Xu, Wenhua Liang, Chunrong Ju, Jian Wang, Karsten Kristiansen, Jianxing He, Mingzhi Ye	1
8	Next generation sequencing-based molecular profiling of lung adenocarcinoma using pleural effusion specimens 2018 ·Journal of Thoracic Disease ·Liping Liu, Ди Шао, Qiuhua Deng, Hailing Tang, Jingjing Wang, Jilong Liu, (unknown), Yongping Lin, Zhiyu Peng, Mao Mao, Karsten Kristiansen, Mingzhi Ye, Jianxing He	31
9	UGT1A1 polymorphisms with irinotecan-induced toxicities and treatment outcome in Asians with Lung Cancer: a meta-analysis 2017 ·Cancer Chemotherapy and Pharmacology ·Xuewei Chen, Liping Liu, Zhihua Guo, Wenhua Liang, Jiaxi He, Liyan Huang, Qiuhua Deng, Hailin Tang, Hui Pan, Minzhang Guo, Yang Liu, Qihua He, Jianxing He	26
10	CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency 2017 ·Scientific Reports ·Xinru Wei, Yunxin Lai, Baiheng Li, Le Qin, (unknown), Simiao Lin, Suna Wang, Qiting Wu, (unknown), Guohua Huang, Qiuhua Deng, Pentao Liu, Donghai Wu, Liangxue Lai, Yao Yao, Peng Li	8
11	Erlotinib intercalating pemetrexed/cisplatin versus erlotinib alone in Chinese patients with brain metastases from lung adenocarcinoma: a prospective, non-randomised, concurrent controlled trial (NCT01578668) 2017 ·ESMO Open ·Haihong Yang, Qiuhua Deng, Yuan Qiu, Jun Huang, Yubao Guan, (unknown), Xin Xu, Xinyun Yang	6
12	Assessment of ALK gene fusions in lung cancer using the differential expression and exon integrity methods 2016 ·Oncology Letters ·Qing Huang, Qiuhua Deng, Lei Jiang, Rong Fang, Yinghua Qiu, Ping Wang, Jeff X. Zhou, Haihong Yang	3
13	Prognostic value of ERCC1, RRM1, and TS proteins in patients with resected non-small cell lung cancer 2015 ·Cancer Chemotherapy and Pharmacology ·Yuwen He, Meiling Zhao, Xinyun Yang, (unknown), Qiuhua Deng, Jianxing He	12
14	MicroRNA-26a/b Regulate DNA Replication Licensing, Tumorigenesis, and Prognosis by Targeting CDC6 in Lung Cancer 2014 ·Molecular Cancer Research ·Xin Zhang, Dakai Xiao, Ziyi Wang, Yongxin Zou, Liyan Huang, (unknown), Qiuhua Deng, Hui Pan, Jiangfen Zhou, Chun Liang, Jianxing He	55
15	Sensitive Detection of EGFR Mutations in Cerebrospinal Fluid from Lung Adenocarcinoma Patients with Brain Metastases 2014 ·Journal of Molecular Diagnostics ·Haihong Yang, Linbo Cai, Yalei Zhang, (unknown), Qiuhua Deng, Meiling Zhao, Xin Xu	43
16	Association between epidermal growth factor receptor gene copy number and ERCC1, BRCA1 protein expression in Chinese patients with non-small cell lung cancer 2014 ·Medical Oncology ·Yalei Zhang, Haihong Yang, Yuan Qiu, Qiuhua Deng, Jun Liu, Meiling Zhao, Ping He, (unknown), (unknown), Jianxing He	5
17	Erlotinib in combination with pemetrexed/cisplatin for leptomeningeal metastases and cerebrospinal fluid drug concentrations in lung adenocarcinoma patients after gefitinib faliure 2014 ·Targeted Oncology ·Haihong Yang, Xinyun Yang, Yalei Zhang, Xin Liu, Qiuhua Deng, Meiling Zhao, Xin Xu, Jianxing He	26
18	Heat shock protein‐60 expression was significantly correlated with the prognosis of lung adenocarcinoma 2011 ·Journal of Surgical Oncology ·Xin Xu, Wei Wang, Wenlong Shao, Weiqiang Yin, Hanzhang Chen, Yuan Qiu, (unknown), Jin Zhao, Qiuhua Deng, Jianxing He	33
19	The expression of p33ING1, p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer 2011 ·Tumor Biology ·Jun Liu, Yongping Lin, Haihong Yang, Qiuhua Deng, Guoqin Chen, Jianxing He	28
20	Establishment and characterization of a new drug surviving cell line Am1010, derived directly from muscle metastases of a human lung adenocarcinoma patient with multi-drug-resistance to cisplatin, taxol, and gefitinib 2010 ·Acta Pharmacologica Sinica ·Huiling Li, Siming Xie, Liang Zhang, (unknown), Wei Wang, Jun Huang, (unknown), (unknown), Qiuhua Deng, Nanshan Zhong, Jianxing He	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact